APA

Jung K., Brux B., Knäbich A., Lein M., Sinha P., Schnorr D. & Loening S. A. (19990315). A gap between total prostate-specific antigen and the sum of free prostate-specific antigen plus alpha1-antichymotrypsin-prostate- specific antigen in patients with prostate carcinoma but not in those with benign prostate hyperplasia. : Clinical chemistry.

Chicago

Jung K, Brux B, Knäbich A, Lein M, Sinha P, Schnorr D and Loening S A. 19990315. A gap between total prostate-specific antigen and the sum of free prostate-specific antigen plus alpha1-antichymotrypsin-prostate- specific antigen in patients with prostate carcinoma but not in those with benign prostate hyperplasia. : Clinical chemistry.

Harvard

Jung K., Brux B., Knäbich A., Lein M., Sinha P., Schnorr D. and Loening S. A. (19990315). A gap between total prostate-specific antigen and the sum of free prostate-specific antigen plus alpha1-antichymotrypsin-prostate- specific antigen in patients with prostate carcinoma but not in those with benign prostate hyperplasia. : Clinical chemistry.

MLA

Jung K, Brux B, Knäbich A, Lein M, Sinha P, Schnorr D and Loening S A. A gap between total prostate-specific antigen and the sum of free prostate-specific antigen plus alpha1-antichymotrypsin-prostate- specific antigen in patients with prostate carcinoma but not in those with benign prostate hyperplasia. : Clinical chemistry. 19990315.